These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 23637579)

  • 61. Impact of parathyroidectomy on kidney graft function in post-transplant tertiary hyperparathyroidism: a comparative study.
    Frey S; Goronflot T; Blanchard C; Kerleau C; Gourraud PA; Wargny M; Caillard C; Hourmant M; Figueres L; Mirallié É;
    Langenbecks Arch Surg; 2022 Sep; 407(6):2489-2498. PubMed ID: 35596781
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
    ; Chertow GM; Block GA; Correa-Rotter R; Drüeke TB; Floege J; Goodman WG; Herzog CA; Kubo Y; London GM; Mahaffey KW; Mix TC; Moe SM; Trotman ML; Wheeler DC; Parfrey PS
    N Engl J Med; 2012 Dec; 367(26):2482-94. PubMed ID: 23121374
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Vascular Calcification - Pathological Mechanism and Clinical Application - . The effect of cinacalcet on vascular calcification].
    Yokoyama K
    Clin Calcium; 2015 May; 25(5):729-36. PubMed ID: 25926577
    [TBL] [Abstract][Full Text] [Related]  

  • 64. What have we learned about chronic kidney disease-mineral bone disorder from the EVOLVE and PRIMO trials?
    Moe SM; Thadhani R
    Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):651-5. PubMed ID: 24100218
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cinacalcet in the treatment of hypercalcaemia and control of hyperparathyroidism due to ectopic parathyroid glands.
    Picazo Sánchez M; Cuxart Pérez M; Sans Lorman R; Sardà Borroy C
    Nefrologia; 2011; 31(1):126-7. PubMed ID: 21270934
    [No Abstract]   [Full Text] [Related]  

  • 66. Mortality in dialysis patients with cinacalcet use: A large observational registry study.
    Friedl C; Reibnegger G; Kramar R; Zitt E; Pilz S; Mann JFE; Rosenkranz AR
    Eur J Intern Med; 2017 Jul; 42():89-95. PubMed ID: 28499709
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis.
    Charytan C; Coburn JW; Chonchol M; Herman J; Lien YH; Liu W; Klassen PS; McCary LC; Pichette V
    Am J Kidney Dis; 2005 Jul; 46(1):58-67. PubMed ID: 15983958
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cinacalcet reduces plasma intact parathyroid hormone, serum phosphate and calcium levels in patients with secondary hyperparathyroidism irrespective of its severity.
    Frazão JM; Messa P; Mellotte GJ; Geiger H; Hagen EC; Quarles LD; Kerr PG; Baños A; Dehmel B; Urena P
    Clin Nephrol; 2011 Sep; 76(3):233-43. PubMed ID: 21888861
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review.
    van der Plas WY; Dulfer RR; Engelsman AF; Vogt L; de Borst MH; van Ginhoven TM; Kruijff S;
    Nephrol Dial Transplant; 2017 Nov; 32(11):1902-1908. PubMed ID: 28402557
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cinacalcet treatment in dialysis patients with secondary hyperparathyroidism: effects and open issues.
    Drüeke TB
    Ther Apher Dial; 2008 Oct; 12 Suppl 1():S2-12. PubMed ID: 19032522
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K
    Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Calcium-Sensing Receptor Genotype and Response to Cinacalcet in Patients Undergoing Hemodialysis.
    Moe SM; Wetherill L; Decker BS; Lai D; Abdalla S; Long J; Vatta M; Foroud TM; Chertow GM
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1128-1138. PubMed ID: 28630081
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism.
    Marcocci C; Chanson P; Shoback D; Bilezikian J; Fernandez-Cruz L; Orgiazzi J; Henzen C; Cheng S; Sterling LR; Lu J; Peacock M
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2766-72. PubMed ID: 19470620
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Retrospective assessment of effective and safety of cinacalcet for the treatment of secondary hyperparathyroidism depending on basal iPTH level].
    Mercadal Orfila G; Blasco Mascaró I
    Farm Hosp; 2012; 36(1):11-5. PubMed ID: 21514862
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis.
    Narayan R; Perkins RM; Berbano EP; Yuan CM; Neff RT; Sawyers ES; Yeo FE; Vidal-Trecan GM; Abbott KC
    Am J Kidney Dis; 2007 Jun; 49(6):801-13. PubMed ID: 17533023
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dysphoria induced in dialysis providers by secondary hyperparathyroidism.
    Soomro IH; Goldfarb DS
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):9-11. PubMed ID: 25516914
    [No Abstract]   [Full Text] [Related]  

  • 77. Surgery for Renal Hyperparathyroidism in the Era of Cinacalcet: A Single-Center Experience.
    Mogl MT; Skachko T; Dobrindt EM; Reinke P; Bures C; Pratschke J; Rayes N
    Scand J Surg; 2021 Mar; 110(1):66-72. PubMed ID: 31906794
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Effect of cinacalcet on parathyroid hormone level in hypercalcemic hyperparathyroidism of patients with renal transplantation].
    Vaquero E; Esteban de la Rosa RJ; Oliva N; Fernández Castillo R; Fernández Gallegos R; Bravo Soto J
    Med Clin (Barc); 2012 Apr; 138(8):323-6. PubMed ID: 21492884
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The conundrum of parathyroidectomy vs cinacalcet for treatment of post-transplant hyperparathyroidism.
    Patel R; Santos RD
    J Bras Nefrol; 2020; 42(3):264-265. PubMed ID: 32840556
    [No Abstract]   [Full Text] [Related]  

  • 80. Comparison between calcitriol and calcitriol plus low-dose cinacalcet for the treatment of moderate to severe secondary hyperparathyroidism in chronic dialysis patients.
    Lee YT; Ng HY; Kuo CC; Chen TC; Wu CS; Chiu TT; Lee WC; Lee CT
    Nutrients; 2013 Apr; 5(4):1336-48. PubMed ID: 23603995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.